tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ATRA is currently covered by 7 analysts with an average price target of $63.5. This is a potential upside of $52.11 (457.51%) from yesterday's end of day stock price of $11.39.
Atara Biotherapeutics's activity chart (see below) currently has 68 price targets and 77 ratings on display. The stock rating distribution of ATRA is 47.37% BUY, 15.79% SELL and 36.84% HOLD.
Analysts average stock forecasts to be materialized ratio is 37.92% with an average time for these price targets to be met of 68.9 days.
Highest price target for ATRA is $25, Lowest price target is $10, average price target is $21.75.
Most recent stock forecast was given by JOHN NEWMAN from CANACCORD on 11-Mar-2025. First documented stock forecast 03-Dec-2015.
Currently out of the existing stock ratings of ATRA, 9 are a BUY (47.37%), 3 are a SELL (15.79%), 7 are a HOLD (36.84%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$17
$5.48 (47.57%)
$17
4 months 27 days ago
(11-Mar-2025)
2/6 (33.33%)
$10.39 (157.19%)
59
Hold
6 months 10 days ago
(28-Jan-2025)
1/4 (25%)
$376.5 (88.90%)
175
Hold
$10
$-1.52 (-13.19%)
$125
8 months 25 days ago
(13-Nov-2024)
2/6 (33.33%)
$-4.26 (-29.87%)
33
Buy
$25
$13.48 (117.01%)
11 months 22 days ago
(16-Aug-2024)
0/4 (0%)
$17.99 (256.63%)
Sell
$35
$23.48 (203.82%)
$75
1 years 11 months 17 days ago
(21-Aug-2023)
13/13 (100%)
$-0.25 (-0.71%)
298
What is ATRA (Atara Biotherapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ATRA (Atara Biotherapeutics) with a proven track record?
Which analyst has the most public recommendations on ATRA (Atara Biotherapeutics)?
Which analyst is the currently most bullish on ATRA (Atara Biotherapeutics)?
Which analyst is the currently most reserved on ATRA (Atara Biotherapeutics)?
